Antiviral chemistry & chemotherapy, 2006-10, Vol.17 (5), p.285-289
2006
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Antiviral Activity of Nucleoside Analogues against SARS-coronavirus (SARS-CoV)
- Ist Teil von
- Antiviral chemistry & chemotherapy, 2006-10, Vol.17 (5), p.285-289
- Ort / Verlag
- London, England: SAGE Publications
- Erscheinungsjahr
- 2006
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- The recent outbreak of severe acute respiratory syndrome (SARS), which is an acute respiratory illness, is caused by newly discovered SARS coronavirus (SARS-CoV). Herein we describe the antiviral activity of several classes of nucleoside analogues evaluated against SARS-CoV in Vero 76 cells, some of which exhibited moderate activity.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 2040-2066, 0956-3202eISSN: 2040-2066DOI: 10.1177/095632020601700506Titel-ID: cdi_proquest_miscellaneous_68259880
- Format
- –
- Schlagworte
- Animals, Antibiotics. Antiinfectious agents. Antiparasitic agents, Antiretroviral drugs, Antiviral activity, Antiviral agents, Antiviral Agents - chemistry, Antiviral Agents - pharmacology, Biological and medical sciences, Cercopithecus aethiops, Coronaviridae, Coronaviruses, Human viral diseases, Infectious diseases, Medical sciences, Microbial Sensitivity Tests, Molecular Structure, Nucleoside analogs, Nucleosides - chemistry, Nucleosides - pharmacology, Pharmacology. Drug treatments, SARS Virus - drug effects, Severe acute respiratory syndrome, Structure-Activity Relationship, Vero Cells, Viral diseases, Viral diseases of the respiratory system and ent viral diseases, Virus Replication - drug effects